Page 8 - Diagnostics Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana
PH, Singapore co-leading ASEAN study on regional populations immune response to COVID-19 vaccination – Manila Bulletin
mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
DCN Dx Acquires Point-Of-Care Diagnostics Development Company PortaScience
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Singapore enhances neutralizing antibody testing service
Singapore enhances neutralizing antibody testing service 12 April 2021 | News
Image credit- prnewswire
GenScript Biotech Corporation, Parkway Laboratories and the Diagnostics Development (DxD) Hub announced their collaboration to provide the cPass™ SARS-CoV-2 neutralizing antibody test in Singapore through Parkway s panel of specialist and GP clinics.
Neutralizing antibodies are a small percentage of antibodies that bind to sites on the virus and inhibit entry of that virus into the host. Unlike the many COVID-19 lab-based antibody test kits commercially available, cPass™ can detect functional neutralizing antibodies.
Traditionally, measuring neutralizing antibodies requires the use of live virus, cells, highly skilled operators, and complex laboratory procedures that require several days in the laboratory to obtain results and limit their widespread use.
New partnership to develop test for predicting disease course in pediatric Crohn s patients
The Crohn s & Colitis Foundation, the leading non-profit organization focused on both research and patient support for inflammatory bowel disease (IBD), has entered into a partnership with LifeArc, an independent medical research charity that advances translation of early science into health care treatments or diagnostics, to potentially develop the first clinical lab test to predict disease course in pediatric patients with Crohn s disease and response to treatment.
A prognostic test which could accurately predict which children will develop complications and identify patients most likely to benefit from anti-TNF therapy would help clinicians make effective early treatment decisions to improve outcomes.
Global Biomarker Market 2020 Research Analysis on Competitive landscape and Key Vendors, Forecast by 2025
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.